The Ledger

Risant Health, the Kaiser Permanente-backed nonprofit, signed Wednesday to take in Integris Health, Oklahoma’s largest health system, at a moment when Integris says it expects to lose more than $130 million of revenue next year. Per the Risant Health announcement, Integris runs 10 acute care and 10 specialty hospitals, the state’s largest physician network and about 13,000 employees, and will keep its name, medical staff and leadership. Financial terms and a closing timeline were not disclosed, and the deal needs regulatory approval. The finances come from Healthcare Dive (supplemental, citing Integris bond filings we could not open): net income fell to $12 million in fiscal 2025 from almost $27 million, S&P Global Ratings downgraded the system in 2025, and Integris expects revenue losses of more than $130 million in 2026 tied to Medicare and Medicaid cuts and service line and staff reductions. This is Risant’s third system after Geisinger in 2024 and Cone Health in 2025. Who it hits: Oklahoma payers and independent physicians who contract with Integris, which says it will keep working with other health plans, and any midsize nonprofit weighing a sale against a capital partner. So what: the pattern is a thin-margin system trading independence for investment it says it “couldn’t make or build on our own.” Confidence: High on the agreement and Integris footprint (primary announcement); Med on the financial figures (trade report of filings); Low on price and timing.

Quest Diagnostics disclosed unauthorized access to the system its clients use to order tests and read results, the same day it reported earnings. In an 8-K filed October 22, the clinical laboratory giant said it learned October 21 of unauthorized access to its Quanum Lab Services Manager, notified federal law enforcement and hired outside cybersecurity experts. It believes an unauthorized party accessed certain patient records; the full scope is under investigation, and the filing says the incident has not materially disrupted operations or the ability to serve patients. Quest’s Quanum notice, updated 8:00 a.m. Eastern today, says access was discontinued, full service could return as soon as today, and providers can use paper requisitions or Quanum eLabs meanwhile. No patient count, record types or financial estimate has been given. Who it hits: physician practices and health systems that order Quest tests through the portal, and Quest’s cyber insurers and regulators if the count is large. So what: the filing speaks only to operations, not to whether the incident is financially material, so the cost is still unknown. Confidence: High on the disclosure (primary filing and company notice); Low on scope and cost.

Hackensack Meridian Health signed a definitive agreement Tuesday to take in Hunterdon Health, pledging $200 million plus $30 million for an electronic health record. Per Healthcare Dive (supplemental; we did not retrieve a company release), the New Jersey nonprofits’ boards have approved the deal, which still needs state regulatory approval and federal antitrust review. The $30 million funds Epic across Hunterdon’s care sites. Hunterdon operates the 184-bed Hunterdon Medical Center and employs more than 3,000 people, with operating income of more than $11 million last year, up from $1.7 million in 2024. Fitch estimates Hunterdon would be about 5% of Hackensack Meridian’s revenue and calls the deal credit neutral. Who it hits: independent hospitals in central New Jersey and the commercial payers negotiating with a larger system. No closing date was given. Confidence: Med (trade reporting; primary documents not retrieved).

Centene reports third-quarter results Tuesday, and the Medicaid and Marketplace comparison is already set. The release is scheduled for October 27 per a finviz copy of the company notice (supplemental; not confirmed on Centene’s investor site), and Tenet Healthcare reports October 29 before the market opens, per a finviz copy of its notice (supplemental). Molina’s Medicaid ratio of 93.0% and Marketplace ratio of 92.5% are the yardstick for Centene; for Tenet, the open question is how much uninsured volume is hitting hospital payer mix. Confidence: Med on dates; no claims about results.

THE DEAL SHEET

Scan covered SEC filings, company releases and trade press for October 21 to 23. HCA reports later this month and Tenet on October 29, so no provider earnings landed in the window. No health system bankruptcy, rating action, closure, or FTC or DOJ healthcare merger action dated in the window could be confirmed from a primary source. MultiCare and Samaritan close their combination November 1; that is a closing, not a new transaction. Frontier scan this run: fertility clinic and IVF networks, no fresh October 2026 deal found.